Placebo in new Covid-19 vaccine trials: data quality prioritised over participants' rights.
Indian J Med Ethics
; VI(2): 1-6, 2021.
Artículo
en Inglés
| MEDLINE | ID: covidwho-1206594
ABSTRACT
The WHO Ad Hoc Expert Group on the Next Steps for Covid-19 Vaccine Evaluation makes recommendations on the use of placebo controlled trials in ongoing and future Covid-19 vaccine research. These recommendations unequivocally prioritise data quality over participants' rights and safety. Participants in trials of vaccines which have received emergency use listing or authorisation would be refused available vaccines. Placebo-controlled trials that would be impossible to conduct in rich countries would be permitted in poor countries. If these suggestions are implemented, the major beneficiary will be the vaccine industry.
Texto completo:
Disponible
Colección:
Bases de datos internacionales
Base de datos:
MEDLINE
Asunto principal:
Placebos
/
Derechos del Paciente
/
Ética Médica
/
Vacunas contra la COVID-19
/
COVID-19
Tipo de estudio:
Estudio experimental
/
Ensayo controlado aleatorizado
Tópicos:
Vacunas
Límite:
Adulto
/
Anciano
/
Femenino
/
Humanos
/
Masculino
/
Middle aged
Idioma:
Inglés
Revista:
Indian J Med Ethics
Asunto de la revista:
Etica
Año:
2021
Tipo del documento:
Artículo
Similares
MEDLINE
...
LILACS
LIS